Objective: to correlate the detection rate of high risk HPV (HR-HPV) DNA between self-collected and clinician-collected testing. Materials and methods: A cross-sectional analytic study was conducted in 400 women undergoing cervical cancer screening program during February and May 2015. The procedure began with self-collected method and then clinician-collected method. Then, the specimens were processed and interpreted with the same technique. If the results from either methods were positive for HPV genotype 16 or 18, colposcopy was performed. We also conducted cytology testing for the participants. If the results were abnormal (ASC-US+), colposcopy was also performed. Results: The detection rate of HR-HPV DNA was 10.0% and 7.5% by self-collected and clinician-collected specimen, respectively (kappa = 0.73). HR-HPV positive rate in cytology ASC-US+ was no significantly different between groups. HR-HPV DNAs were positive in every HSIL (100% detection rate). HPV DNA test positive for detection CIN+ was not significantly different between self-collected and clinician-collected testing. Conclusion: self-collected HPV testing can be used as an alternative option for primary cervical screening program. Detection rate of high grade lesion is similar to clinician-collected test.
Nutthachote, P., Oranratanaphan, S., Termrungruanglert, W., Triratanachat, S., Chaiwongkot, A., Baedyananda, F., & Bhattarakosol, P. (2019). Comparison of detection rate of high risk HPV infection between self-collected HPV testing and clinician-collected HPV testing in cervical cancer screening. Taiwanese Journal of Obstetrics and Gynecology, 58(4), 477–481. https://doi.org/10.1016/j.tjog.2019.05.008